You just read:

Bausch + Lomb Begins Distribution Of VYZULTA™ (latanoprostene bunod ophthalmic solution), 0.024% To U.S. Wholesalers

News provided by

Valeant Pharmaceuticals International, Inc.

Dec 18, 2017, 08:00 ET